Oliver J. Muensterer

Prof. Oliver J. Muensterer

LMU Klinikum, Munich, Bavaria, Germany
+1
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in International Journal of Surgery
Verified
Journal Article
Closed access
Oliver J. MuenstererOliver J. Muensterer
Oliver J. Muensterer
MLMartin Lacher
Martin Lacher
CZChristoph Zoeller
Christoph Zoeller
MBMatthew Bronstein
Matthew Bronstein
JKJoachim Kübler
Joachim Kübler
Personal portable information technology is advancing at a breathtaking speed. Google has recently introduced Glass, a device that is worn like conventional glasses, but that combines a computerized central processing unit, touchpad, display screen, high-definition camera, microphone, bone-conduction transducer, and wireless connectivity. We have obtained a Glass device through Google's Explorer program and have tested its applicability in our daily pediatric surgical practice and in relevant experimental settings. Glass was worn daily for 4 consecutive weeks in a University Children's Hospital. A daily log was kept, and activities with a potential applicability were identified. Performance of Glass was evaluated for such activities. In-vitro experiments were conducted where further testing was indicated. Wearing Glass throughout the day for the study interval was well tolerated. Colleagues, staff, families and patients overwhelmingly had a positive response to Glass. Useful applications for Glass were hands-free photo/videodocumentation, making hands-free telephone calls, looking up billing codes, and internet searches for unfamiliar medical terms or syndromes. Drawbacks encountered with the current equipment were low battery endurance, data protection issues, poor overall audio quality, as well as long transmission latency combined with interruptions and cut-offs during internet videoconferencing. Glass has the some clear utility in the clinical setting. However, before it can be recommended universally for physicians and surgeons, substantial improvements to the hardware are required, issues of data protection must be solved, and specialized medical applications (apps) need to be developed.

1 August 2019 in International Journal of Surgery
Verified
Journal Article
Closed access
Oliver J. MuenstererOliver J. Muensterer
Oliver J. Muensterer
EGEmilio Gianicolo
Emilio Gianicolo
Inguinal hernia repair is one of the most frequent operations in pediatric surgery and is increasingly performed laparoscopically. The latter introduced new momentum in the debate on the necessity of contralateral exploration, as the rates of contralateral patent processus vaginales and metachronous inguinal hernias determine whether a routine closure would be overtreatment or useful prevention. We searched MEDLINE via PubMed, Web of Science and Scopus at the 6th of September 2017; reference lists and CrossRef were snowballed for reports citing identified studies. Eligibility criteria were age <18 years, preoperative diagnosis of unilateral hernia, laparoscopic evaluation, and publication since January 2012. Studies using hernioscopy (transinguinal laparoscopy) were excluded. We reported our systematic review following PRISMA criteria. We included 32 reports consisting of 19,188 pediatric patients diagnosed with unilateral inguinal hernia. Of these, 38.5% (95% confidence interval: 34%-43.1%) had a contralateral open processus vaginalis concomitantly found during laparoscopic inguinal hernia repair. A secondary analysis using nine studies that compared open and laparoscopic approaches found that prophylactic closure of contralateral patent processus vaginales resulted in a risk difference of 5.7% (95% confidence interval: 3.6%-7.7%; P < 0.001) following 2691 (42.8%) procedures (nine studies: Ten of 6282 patients operated laparoscopically had a metachronous hernia, versus 286 of 5764 with open hernia repair). Prophylactic closure of a contralateral patent processus vaginalis reduces the number of metachronous inguinal hernias, but about 18 procedures must be performed to prevent one metachronous inguinal hernia, indicating that the indication should be based on personal circumstances of the patient.

25 June 2019 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
OBOlaf Beck
Olaf Beck
Oliver J. MuenstererOliver J. Muensterer
Oliver J. Muensterer
SHSarah Hofmann
Sarah Hofmann
HRHeidi Roßmann
Heidi Roßmann
APAlicia Poplawski
Alicia Poplawski
JGJan Gödeke
Jan Gödeke
Background: Central venous access devices (CVAD) provide important benefits in the management of oncological pediatric patients. However, these catheters are responsible for severe complications. Methods: In this context, we aimed to analyze all patients receiving a CVAD in the Department of Pediatric Hematology and Oncology of the University hospital of Mainz over a period of 9 years, focused on CVAD related complications. Data on demographics, as well as intraoperative and postoperative complications were extracted. Results: A total of 296 patients with a mean age 93.2 ± 62.4 months were analyzed. The majority suffered from leukemia (n = 91, 30.7%), lymphomas (n = 50, 16.9%), and brain tumors (n = 48, 16.2%). In 63 (21.3) patients, complications were observed. No death caused by complications of CVADs was found in our series. Catheter-related blood stream infections (BSI) (7.4%) were most prevalent, followed by dislodgements (5.4%), occlusions (2.7%), thrombosis (2.4%), and catheter leakage (2.4%). Insertion site infections were observed in three patients (1.0%). Fifty-nine percent of all patients with catheter-related BSI suffered from Leukemia. In patients with Catheter-related BSIs we detected the condition leukemia as the underlying disease as a risk factor compared to solid tumors as the underlying disease. Overall, totally implanted devices (ports) have a lower complication rate than tunneled catheter. Conclusion: Implantation of CVADs seems to be safe and reliable in this large pediatric patient cohort. Even if complications occur in the long-term management of CVADs, they can be treated successfully and long-term catheter survival rates are excellent.

17 August 2011 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
MGMatthias Griese
Matthias Griese
JRJan Ripper
Jan Ripper
ASAnke Sibbersen
Anke Sibbersen
PLPia Lohse
Pia Lohse
PLPeter Lohse
Peter Lohse
AHAndreas Hector
Andreas Hector
Clinical presentation, diagnosis, management and outcome of molecularly defined congenital pulmonary alveolar proteinosis (PAP) due to mutations in the GM-CSF receptor are not well known.

3 June 2011 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
Oliver J. MuenstererOliver J. Muensterer
Oliver J. Muensterer
KGKeith E. Georgeson
Keith E. Georgeson

1 November 2021 in Pediatrics
Verified
Journal Article
Closed access
PDF file
Oliver J. MuenstererOliver J. Muensterer
Oliver J. Muensterer
LELauren L. Evans
Lauren L. Evans
ASAlexander Sterlin
Alexander Sterlin
MSMohammad Sahlabadi
Mohammad Sahlabadi
VAVamsi Aribindi
Vamsi Aribindi
MHMichael R. Harrison
Michael R. Harrison
Thoracoscopic esophageal atresia (EA) repair affords many benefits to the patient; however, intracorporeal suturing of the anastomosis is technically challenging. Esophageal magnetic compression anastomosis (EMCA) is a compelling option for endoluminal EA repair, but available EMCA devices have prohibitive rates of recalcitrant stricture. Connect-EA is a new endoluminal EMCA device system that employs 2 magnetic anchors with a unique mating geometry designed to reliably create a robust anastomosis and decrease rates of leak and stricture. We describe our first-in-human experience with this novel endoluminal device for staged EA repair in 3 patients (Gross type A, B, and C) at high risk for conventional surgical repair. First, the esophageal pouches were approximated thoracoscopically. After acute tension subsided, the device anchors were endoscopically placed in the esophageal pouches and mated. Anchors were spontaneously excreted in 2 cases. Endoscopic repositioning and retrieval of the anchors were required in 1 patient because of narrowed esophageal anatomy. There were no perioperative complications. Patients were managed for 14 to 18 months. The strictures that developed in the patients were membranous and responded well to dilation alone, resolving after 4 to 5 outpatient dilations. Gastrostomies were closed between 6 and 11 months and all patients are tolerating full oral nutrition. Early experience with this new endoluminal EMCA device system is highly favorable. The device offers considerable benefit over conventional handsewn esophageal anastomosis and anastomotic outcomes are superior to available EMCA devices.